Brief: SynAct Pharma Q2 Pre-Tax Loss Narrows To SEK 5.9 Mln
Aug 28 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q2 PRE-TAX LOSS SEK 5.9 MILLION VERSUS LOSS 7.3 MILLION
YEAR AGO
Source text for Eikon: ID:nWkr4mLTQm
Further company coverage: SYNACT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development